Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Insulin Resistance Probability Score and Incident Cardiovascular Disease

Insulin Resistance Probability Score and Incident Cardiovascular Disease

Authors: Louie JZ, Shiffman D, McPhaul MJ, Melander O

Citation: J Intern Med. 2023 Jul 9. doi: 10.1111/joim.13687

Specialties: Cardiology, Cardiovascular disease, Endocrinology,

Related content

Conference Presentation
Insulin resistance probability score and cardiovascular events in the elderly
Conference Presentation
Prevalence of High Insulin Resistance Probability Score in a Nation-Wide Working-Age Population
Conference Presentation
Predictors of lack of improvement in glycemic control in persons with type 2 diabetes
Publication
An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project-A Longitudinal Population-Based Study of Older European
Publication
The relationship between insulin resistance and ion mobility lipoprotein fractions
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
Test FAQ
Insulin Intact LC MS MS

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.